The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

This study has been completed.

Study NCT00146289 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: September 2, 2005 Last Updated: September 1, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2005 (Final data collection date for primary outcome measure)